{"id":1045,"date":"2024-02-08T13:22:32","date_gmt":"2024-02-08T00:22:32","guid":{"rendered":"https:\/\/www.aftpharm.com\/au-en\/news\/maxigesic-sponsors-the-one-nz-warriors\/"},"modified":"2024-02-08T13:22:32","modified_gmt":"2024-02-08T00:22:32","slug":"maxigesic-sponsors-the-one-nz-warriors","status":"publish","type":"news","link":"https:\/\/www.aftpharm.com\/au-en\/news\/maxigesic-sponsors-the-one-nz-warriors\/","title":{"rendered":"MAXIGESIC\u00ae SPONSORS THE ONE NZ WARRIORS"},"content":{"rendered":"<p>AFT Pharmaceuticals is thrilled to announce Maxigesic\u00ae will be the Official Pain Relief Partner of the One New Zealand Warriors for the 2024 and 2025 NRL seasons.<\/p>\n<p>The Maxigesic<sup>\u00ae<\/sup> name will feature on the front of the playing shorts for all five of the club\u2019s teams this season in the NRL, New South Wales Cup, Jersey Flegg Cup (under-21), SG Ball Cup (under-19) and Harold Matthews Cup (under-17).<\/p>\n<p>As the club\u2019s official pain relief partner, Maxigesic<sup>\u00ae<\/sup> will also be the presenting partner for a \u2018Big Hit of the Week\u2019 video feature as well as the weekly injury report.<\/p>\n<p>\u201cWe\u2019ve come off a watershed season in 2023 but 2024 is even bigger for us as we field an unprecedented five teams across various competitions,\u201d said One New Zealand Warriors General Manager Commercial and Consumer Business Glenn Critchley. \u201cSo partnering with an innovative brand leader like Maxigesic\u00ae is critical. We\u2019re thrilled to have them on board.\u201d<\/p>\n<p>\u201cWe\u2019re very excited to have Maxigesic<sup>\u00ae<\/sup> partner with the One New Zealand Warriors family and form a perfect combination for the next two seasons,\u201d said Hartley Atkinson, Chief Executive of AFT Pharmaceuticals and inventor of Maxigesic<sup>\u00ae<\/sup>.<\/p>\n<p>\u201cWe feel a real affinity with the One New Zealand Warriors and their journey. Having initially developed and launched Maxigesic\u00ae at home in New Zealand, we\u2019ve taken on the Australian market and established Maxigesic<sup>\u00ae<\/sup> as the number one selling paracetamol\/ibuprofen combination* on the other side of the Tasman, so we\u2019re fully supportive of the One New Zealand Warriors achieving their own historic milestone of winning a first NRL title. \u201cBy bringing Maxigesic<sup>\u00ae<\/sup> and the One New Zealand Warriors together, we\u2019re confident that we Kiwis are going to fly, both at home and away, in the 2024 season.\u201d<\/p>\n<p>Maxigesic<sup>\u00ae<\/sup> was developed as a smarter alternative that provides faster and more effective pain relief than other analgesics, particularly those containing opioids, and is clinically proven to provide 78% more effective pain relief than Paracetamol alone and 36% more effective pain relief than Ibuprofen alone<sup>1<\/sup>.<\/p>\n<p><em><strong>Ref.<\/strong> 1: Two tablets of MAXIGESIC\u00ae four times per day provides more effective pain relief than a full daily dose of Paracetamol or Ibuprofen given in four divided doses. Claim based on trials of postoperative pain relief after removal of 1\u20134 wisdom teeth. Daniels et al (2018). Research sponsored by AFT Pharmaceuticals.<\/em><\/p>\n<p><em>*Source: Circana Total Australian Pharmacy sales data \u2013 MAT unit and dollar sales to 17\/12\/23<\/em><\/p>\n<p><strong>For inquiries please contact:<\/strong><br \/>\nRichard Becht<br \/>\nMedia Manager<br \/>\nOne New Zealand Warriors<br \/>\nMobile: +64 21 814 537<br \/>\nEmail: richard@warriors.kiwi<\/p>\n","protected":false},"excerpt":{"rendered":"<p>AFT Pharmaceuticals announces Maxigesic\u00ae is the new Official Pain Relief Partner of the One New Zealand Warriors for the 2024 and 2025 NRL seasons.<\/p>\n","protected":false},"author":9,"featured_media":396,"template":"","news_tag":[],"class_list":["post-1045","news","type-news","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/www.aftpharm.com\/au-en\/wp-json\/wp\/v2\/news\/1045","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aftpharm.com\/au-en\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.aftpharm.com\/au-en\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.aftpharm.com\/au-en\/wp-json\/wp\/v2\/users\/9"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.aftpharm.com\/au-en\/wp-json\/wp\/v2\/media\/396"}],"wp:attachment":[{"href":"https:\/\/www.aftpharm.com\/au-en\/wp-json\/wp\/v2\/media?parent=1045"}],"wp:term":[{"taxonomy":"news_tag","embeddable":true,"href":"https:\/\/www.aftpharm.com\/au-en\/wp-json\/wp\/v2\/news_tag?post=1045"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}